
Nicholas Saraceno
Editor at Pharmaceutical Commerce
Editor at @pharmacommerce and co-host of #HenleysAndVnecks. Former Tape Op with @CBSSportsRadio. Graduate from @FloridaAtlantic. #OwlNation
Articles
-
1 week ago |
pharmaceuticalcommerce.com | Nicholas Saraceno
In a video interview with Pharma Commerce, Michael Rowe, Two Labs’ senior director of DSCSA/serialization compliance services, describes how the HDA Distribution Management Conference (DMC) covers a broad spectrum of topics within the pharmaceutical supply chain, with a special focus on current regulatory and operational challenges. One of the major topics at this year’s conference was the Drug Supply Chain Security Act (DSCSA), which prompted several discussions and roundtable sessions.
-
1 week ago |
pharmaceuticalcommerce.com | Nicholas Saraceno
Antares Vision Group, a provider of track-and-trace systems for several fields including the life sciences, is growing its solutions portfolio to now include precision labeling equipment. The company is collaborating with Siempharma, a manufacturer of packaging machines, by welcoming the ETF-300.1This machine is capable of working with containers ranging from 40-180 mm in height, and 22-80 mm in diameter. It can apply labels as tall as 100 mm at speeds of up to 80 meters per minute.
-
1 week ago |
pharmaceuticalcommerce.com | Nicholas Saraceno
In a video interview with Pharma Commerce, Michael Rowe, Two Labs’ senior director of DSCSA/serialization compliance services, describes how the HDA Distribution Management Conference (DMC) covers a broad spectrum of topics within the pharmaceutical supply chain, with a special focus on current regulatory and operational challenges. One of the major topics at this year’s conference was the Drug Supply Chain Security Act (DSCSA), which prompted several discussions and roundtable sessions.
-
2 weeks ago |
pharmaceuticalcommerce.com | Nicholas Saraceno
The afternoon sessions here on day 3 of Asembia continued its impressive slate, with its various business seminars as proof.
-
2 weeks ago |
pharmaceuticalcommerce.com | Nicholas Saraceno
The final day of education at Asembia’s AXS25 Summit kicked off with a multitude of early morning sessions, including one focused on “Beyond Limits: Rethinking Drug Distribution to Drive Patient-Centered Care.” Led by Mike Reff, RPh, MBA, executive director and founder of NCODA (Network for Collaborative Oncology Development & Advancement), he was joined by the esteemed panel of Desi Kotis, BSPharm, PharmD, FASHP, chief pharmacy executive, UCSF Health; Frank Scimeca, PharmD, MBA, BCOP, vice...
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 292
- Tweets
- 1K
- DMs Open
- No

On behalf of @Clin_Trials, I’m here reporting live from Philadelphia for #DPHARM2024 on a quest to discover the latest innovations in the clinical research space. Stay tuned for my session coverage and video interviews, as I explore all that the conference has to offer. https://t.co/l3rz8TwwDu

And just like that, another issue of Pharma Commerce is in the books. Our #August issue does a wonderful job of covering the below, alongside an examination of #BigPharma Inventories and a look at the US drug wholesaling market.

🚨Our August issue is LIVE🚨 #Biotech’s achilles’ heel▪️#Pharmacydeserts becoming a national problem▪️Enhancing #patientaccess and #patientsupport through technology▪️and so much more right here ➡️ https://t.co/WjcztUpP9q https://t.co/ZjGBqo1pYR

I'm very proud of all the content that PC's April issue delivers. We dive into the #pharma #coldchain, #patientadherence tools, the role of #PBMs, and much more. And if you happen to be at #LogiPharmaEurope, you can check it out for yourself by grabbing a print copy!

🚨Our April issue is LIVE🚨 Fresh Views on #PAP2024 and Patient Hubs▪️The power of patient #adherence tools in improving the patient journey▪️Navigating changes and trends in the #pharmasupplychain #PostDSCSA ▪️ and so much more right here ➡️https://t.co/TNH9EOFLdY https://t.co/WjlKG4BS3q